Food intake enhances thromboxane receptor-mediated platelet activation in type 2 diabetic patients but not in healthy subjects

Diabetes Care

Volumn 30, Issue 1, 2007, Pages 138-140

  Razmara, Masoud ^a   Hjemdahl, Paul ^a   Yngen, Marianne ^a   Östenson, Claes Göran ^a   Wallén, N Håkan ^a,b   Li, Nailin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Sweden Karolinska Institutet Department of Clinical Sciences Danderyd Hospital Stressrehab FoU Danderyd   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLIBENCLAMIDE; REPAGLINIDE; THROMBIN; THROMBOXANE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; FOOD INTAKE; HUMAN; LEUKOCYTE AGGREGATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; THROMBOCYTE AGGREGATION;

ADULT; DIABETES MELLITUS, TYPE 2; ENERGY INTAKE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; REFERENCE VALUES;

EID: 33845971267     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1121     Document Type: Article

References (13)

1. Colwell JA, Nesto RW: The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care 26:2181-2188, 2003
2. Ferroni P, Basili S, Falco A, Davi G: Platelet activation in type 2 diabetes mellitus. J Thromb Haemost 2:1282-1291, 2004
3. Hu H, Li N, Yngen M, Östenson C-G, Wallén NH, Hjemdahl P: Enhanced leukocyte-platelet cross-talk in type 1 diabetes mellitus: relationship to microangiopathy. J Thromb Haemost 2:58-64,2004
4. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86, 2002
5. Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A: Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 26:3264-3272, 2003
6. Ceriello A: Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54:1-7, 2005
7. Yngen M, Östenson C-G, Hjemdahl P, Wallén NH: Meal-induced platelet activation in type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide. Diabet Med 23:134-140, 2006
8. Massucco P, Mattiello L, Russo I, Traversa M, Doronzo G, Anfossi G, Trovati M: High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism. Thromb Haemost 93:517-526, 2005
9. Sudic D, Razmara M, Forslund M, Ji Q, Hjemdahl P, Li N: High glucose levels enhance platelet activation: involvement of multiple mechanisms. Br J Haematol 133:315-322, 2006
10. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85:2970-2973, 2000
11. Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dandona P: Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr 80:51-57, 2004
12. Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM: Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 41:1071-1077, 2003
13. Perneby C, Wallen NH, Rooney C, Fitzgerald D, Hjemdahl P: Dose- and time-dependent antiplatelet effects of aspirin. Thromb Haemost 95:652-658, 2006